In a major settlement with the Federal Trade Commission, Cigna's pharmacy benefit manager, Express Scripts, has agreed to overhaul its drug pricing practices, particularly for insulin, a move regulators estimate could save patients billions over the next decade.
Brookfield Asset Management (BAM) reported robust fourth-quarter and full-year 2025 results, highlighted by record fee-related earnings and a 15% dividend increase. The alternative asset giant also announced the appointment of Connor Teskey as CEO, signaling a planned leadership transition, while outlining an aggressive growth strategy centered on AI infrastructure and private wealth expansion for 2026.
Market volatility can test any investor's resolve. We analyze six monthly dividend ETFs designed to provide income and potential stability when markets turn south, examining their strategies, holdings, and historical performance.
While Synchrony Financial's stock has trailed the S&P 500, Wall Street maintains a cautiously optimistic outlook, with price targets suggesting significant potential upside amid a challenging environment for consumer finance.
As Qualcomm prepares to report Q1 FY2026 earnings, the chipmaker faces a pivotal moment. Mounting competition from Apple's in-house modems, a slowing handset market, and regulatory pressures in China have investors on edge, setting the stage for a report that could redefine the stock's trajectory.
Passages from Jill Biden's 2019 memoir, describing the devastation of her first divorce, gain new context as her former spouse, William Stevenson, is indicted for the murder of his current wife.
With household electricity costs remaining a significant burden, experts outline a clear path to savings, from navigating deregulated markets to simple efficiency upgrades that can curb energy waste.
With a decade of market-beating returns, American Express's unique business model continues to attract investors. But can this financial stalwart sustain its growth amid regulatory threats and a shifting economic landscape?
As market volatility persists, dividend-focused ETFs are gaining attention from retirees seeking income and lower-risk exposure. We examine two prominent funds that balance yield, stability, and cost-effectiveness for long-term portfolios.
A sharp reversal in institutional ETF flows, weakening U.S. demand, and tightening market liquidity are signaling a potential regime shift for Bitcoin, with analysts warning of further downside risk.
Bitcoin's price action is increasingly mirroring that of beleaguered software equities, with analysts pointing to shared vulnerabilities in the face of artificial intelligence's disruptive rise.
After years of steady but modest expansion, Johnson & Johnson projects a significant acceleration in revenue, driven by a bold ambition to dominate the global oncology market. With shares trading at a premium, analysts debate if the stock's future growth potential justifies its current price.
The sports betting and iGaming joint venture BetMGM reported a dramatic financial turnaround for fiscal 2025, posting $2.8 billion in revenue and $220 million in EBITDA. The company has initiated capital returns to its parent firms and forecasts further growth for 2026, setting the stage for increased distributions to shareholders like Entain.
Bio-Techne's Q2 FY2026 results show flat organic revenue, as robust demand from large pharmaceutical clients countered persistent softness in the biotech and academic sectors. Management highlights strategic growth areas and expects gradual market improvement.
Silicon Motion Technology (SIMO) reported robust Q4 2025 results, surpassing revenue and margin targets, as executives outlined a bullish outlook fueled by AI infrastructure needs, PCIe Gen5 adoption, and strategic market share gains. The company forecasts continued sequential growth through 2026, targeting record annual revenue despite industry-wide memory supply constraints.
Fueled by streaming growth and a series of high-profile catalog acquisitions, Reservoir Media posted strong Q3 results and lifted its full-year guidance, signaling confidence in its diversified rights strategy.
Matthews International (NASDAQ: MATW) reported its fiscal first-quarter 2026 results, showcasing a decisive shift in strategy. The company highlighted significant progress in debt reduction through major divestitures, while doubling down on its core memorialization business and high-value intellectual property like the Propelis venture.
Financial technology provider Jack Henry & Associates reported robust second-quarter results, driven by solid revenue growth and margin expansion. The company raised its full-year guidance for a second consecutive quarter, citing sustained demand from banks and credit unions and a healthy sales pipeline.
IAC closed a 'solid' year with digital revenue growth at its People Inc. division, even as core web traffic declines. Executives outlined a strategic pivot towards off-platform distribution and brand extensions to counter AI-driven search disruption, while increasing its stake in MGM and halting quarterly guidance.
CDW Corporation closed its fiscal 2025 with a robust fourth quarter, surpassing expectations as customer focus on efficiency and security fueled growth in high-margin software, cloud, and services segments. While navigating a cautious IT spending outlook for 2026, the company aims to outpace the broader market.
